Asset Details
Do you wish to reserve the book?
Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs
Do you wish to request the book?
Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs
2017
Overview
Advanced glycation end products (AGEs) are a group of proteins and lipids becoming glycated and oxidized after persistent contact with reducing sugars or short-chain aldehydes with amino group and/or high degree of oxidative stress. The accumulation of AGEs in the body is a natural process that occurs with senescence, when the turnover rate of proteins is reduced. However, increased circulating AGEs have been described to arise at early lifetime and are associated with adverse outcome and survival, in particular in settings of cardiovascular diseases. AGEs contribute to the development of cardiac dysfunction by two major mechanisms: cross-linking of proteins or binding to their cell surface receptor. Recently, growing evidence shows that high-molecular weight AGEs (HMW-AGEs) might be as important as the characterized low-molecular weight AGEs (LMW-AGEs). Here, we point out the targets of AGEs in the heart and the mechanisms that lead to heart failure with focus on the difference between LMW-AGEs and the less characterized HMW-AGEs. As such, this review is a compilation of relevant papers in the form of a useful resource tool for researchers who want to further investigate the role of HMW-AGEs on cardiac disorders and need a solid base to start on this specific topic.
Publisher
Springer Vienna,Springer Nature B.V
Subject
advanced glycation end products
/ Advanced glycosylation end products
/ Age
/ Biomedical and Life Sciences
/ Cardiovascular Diseases - genetics
/ Cardiovascular Diseases - metabolism
/ Cardiovascular Diseases - physiopathology
/ Contractile Proteins - genetics
/ Contractile Proteins - metabolism
/ Glycation End Products, Advanced - chemistry
/ Glycation End Products, Advanced - classification
/ Glycation End Products, Advanced - metabolism
/ Heart
/ Humans
/ Lipids
/ Proteins
/ Receptor for Advanced Glycation End Products - genetics
/ Receptor for Advanced Glycation End Products - metabolism
/ Sugar
